Researchers at Dongguk University in South Korea have developed an [...]

Skylark Bio has dosed the first patient in a Phase [...]

CellProthera and Alfresa Holdings have signed an MOU covering potential [...]

Oncoinvent has published Phase 1 dosimetry data for Radspherin in [...]

Broken String Biosciences has launched BaseMap ABE, a platform designed [...]

Biotech company LifeMine Therapeutics has raised $263 million to support [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

The first UK patient has been dosed with a personalised [...]

Atsena Therapeutics has received EMA orphan designation for two gene [...]

Lonza is expanding its commercial-scale aseptic drug product capacity in [...]